Literature DB >> 812334

Prevalence of mucoid strains of Pseudomonas aeruginosa in bacteriological specimens from patients with cystic fibrosis and patients with other diseases.

N Hoiby.   

Abstract

The relative prevalence of mucoid strains compared with non-mucoid strains of Pseudomonas aeruginosa has been investigated in all routine bacteriological specimens received in a department of clinical microbiology during 1973. Pseudomonas aeruginosa was isolated from 1054 of the specimens (5.7 per cent) representing 53 patients with cystic fibrosis (551 isolates) and 169 patients with other diseases (503 isolates). The relative prevalence of mucoid strains was significantly higher in specimens from patients with cystic fibrosis (80 per cent) than in specimens from patients with other diseases (3 per cent). Considering patients without cystic fibrosis, the relative prevalence of mucoid strains was low in specimens from all anatomical regions, and no special preference of these strains for the respiratory tract could be demonstrated in these patients, in contrast to the situation in patients with cystic fibrosis. Alternation between mucoid strains and non-mucoid strains in subsequent specimens was observed in 33 of the patients.

Entities:  

Mesh:

Year:  1975        PMID: 812334

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand Suppl


  10 in total

1.  Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways.

Authors:  K B Adler; D D Hendley; G S Davis
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

2.  Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model.

Authors:  Alessandra Bragonzi; Dieter Worlitzsch; Gerald B Pier; Petra Timpert; Martina Ulrich; Morten Hentzer; Jens Bo Andersen; Michael Givskov; Massimo Conese; Gerd Doring
Journal:  J Infect Dis       Date:  2005-06-24       Impact factor: 5.226

3.  Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients.

Authors:  S Silbert; A L Barth; H S Sader
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis.

Authors:  Nadine Hoffmann; Thomas Bovbjerg Rasmussen; Peter Østrup Jensen; Charlotte Stub; Morten Hentzer; Søren Molin; Oana Ciofu; Michael Givskov; Helle Krogh Johansen; Niels Høiby
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.

Authors:  David A D'Argenio; Manhong Wu; Lucas R Hoffman; Hemantha D Kulasekara; Eric Déziel; Eric E Smith; Hai Nguyen; Robert K Ernst; Theodore J Larson Freeman; David H Spencer; Mitchell Brittnacher; Hillary S Hayden; Sara Selgrade; Mikkel Klausen; David R Goodlett; Jane L Burns; Bonnie W Ramsey; Samuel I Miller
Journal:  Mol Microbiol       Date:  2007-04       Impact factor: 3.501

Review 6.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 7.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

8.  Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors:  S S Pedersen; F Espersen; N Høiby; G H Shand
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

9.  Genetic rearrangement associated with in vivo mucoid conversion of Pseudomonas aeruginosa PAO is due to insertion elements.

Authors:  P A Sokol; M Z Luan; D G Storey; P Thirukkumaran
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.476

10.  Pseudomonas aeruginosa enhances production of a non-alginate exopolysaccharide during long-term colonization of the cystic fibrosis lung.

Authors:  Holly K Huse; Taejoon Kwon; James E A Zlosnik; David P Speert; Edward M Marcotte; Marvin Whiteley
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.